Clinical trials: Female Sexual Dysfunction
Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause
Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders
Ospemifene is the first oral and non-hormonal treatment for moderate or severe vulvo-vaginal atrophy (VVA) in postmenopausal women who are not candidates to treatment with local oestrogens.
- Conditions
- Vulvovaginal Signs and Symptoms, Genitourinary Syndrome of Menopause, Sexual; Disorder, Arousal, Female
- Trial name
- EROS (NCT04677491)
- Testing
- Ospemifene 60 mg, fMRI experiments
- Where
- Spain
- Volunteers
- 25 people
- Sponsor
- Hospital Clinic of Barcelona
Female Genital Mutilation, Sexual Dysfunctions, Psychological
Sexual Health of Women With Genital Mutilation Seen at the Saint-Denis Women's Center
This study looks at the sexual health of women who have experienced female genital mutilation (FGM) and who are receiving care at the Women's Center at Saint-Denis Hospital.
- Conditions
- Female Genital Mutilation, Sexual Dysfunctions, Psychological, Sexual Health, Violence Against Women
- Trial name
- NCT07027696
- Where
- France
- Volunteers
- 200 people
- Sponsor
- Centre Hospitalier de Saint-Denis
Contraception, Female Sexual Function
The Effect of Sexual Education-Counseling According to PLISSIT in Solving Sexual Problems in Women Using Contraceptive Methods: One Year Follow-up Results
Sexuality is a universal part of human life and is a process in which two people share their emotions, body, soul and pleasures. Although it is a natural part of life, sexuality can be affected by many factors.
- Conditions
- Contraception, Female Sexual Function, Sexual Dysfunction, PLISSIT
- Trial name
- NCT06772883
- Testing
- sexual education and counseling, control group
- Where
- Turkey (Türkiye)
- Volunteers
- 352 people, healthy volunteers welcome
- Sponsor
- Izmir Katip Celebi University